MedPlus continued to benefit from strong sales of products under its private label brands in both the pharmaceuticals and consumer wellness categories, which analysts say contribute more to its ...
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Dream Finders Homes (NYSE:DFH) stands against other stocks that Jim ...